mounjaro semaglutide or tirzepatide vs. Tirzepatide: Which Weight Loss Medication Is Right for You? Tirzepatide more effective in blood

PlexusDx coordinates with your psychiatrist and endocrinologist to ensure all your treatments work in harmony without competing for absorption or creating overlapping side effects

These are not documented at meaningful rates in semaglutide trials

PlexusDx offers both options so you can choose based on your lifestyle and tolerance profile

The key regulatory milestones: FDA Breakthrough Therapy designation for MASH (September 2024) EMA PRIME designation for MASH (November 2023) China NMPA Breakthrough designation (June 2024) Phase 3 trials (SYNCHRONIZE-1 and SYNCHRONIZE-2) fully enrolled, results expected H1 of this year Estimated FDA filing: Late this year at the earliest Estimated FDA approval: Possibly next year, depending on Phase 3 results If Phase 3 results confirm Phase 2 findings, survodutide could reach the market within the next 12-24 months

Reliable chain-of-custody records are especially important when sourcing investigational compounds

Y.ZhouL